Article
Allele-specific suppression of pathogenic bestrophin-1 transcripts by CRISPR/Cas9-mediated genome editing.
Genome medicine - 20 Apr 2026
Milenkovic Andrea, Weber Bernhard H F
Abstract excerpt
BACKGROUND: Treating autosomal dominant gene mutations remains challenging, particularly when mutations convey a gain-of-function or a dominant-negative effect, as standard gene supplementation strategies often fail to counteract the pathogenic allele. METHODS: In this study, we employed human induced pluripotent stem cell-derived retinal pigment epithelium (hiPSC-RPE) to investigate allele-specific CRISPR/Cas9...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
